PURE Financial Facts
Basic and diluted net loss per share: -0.17Total other income (expense): -14K
See Full Income Statement
Total stockholders' equity: 1.74M
Accounts receivable, net: 95K
See Full Balance Sheet
Earnings History for Pure Bioscience (PURE)
|
Expand Research on PURE
| Next EPS Date | 3/18/13 *Est. | EPS Growth Rate | -316.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | N/A | Revenue Growth Rate | -57.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/12/12 |
Q113 | -$0.25 | N/A | N/A | $110K | $257K | N/A / N/A | N/A | 0% | Details | |
| 6/13/12 | Q312 | -$0.04 | N/A | N/A | $207K | $128M | N/A / N/A | N/A | 0% | Details | |
| 3/16/12 |
Q212 | -$0.05 | N/A | N/A | $221K | $68K | N/A / N/A | N/A | 0% | Details | |
| 12/15/11 |
Q112 | -$0.06 | N/A | N/A | $257K | $23K | N/A / N/A | N/A | 0% | Details | |
| 10/31/11 |
Q411 | -$0.05 | N/A | N/A | $244K | $324K | N/A / N/A | N/A | 0% | Details | |
| 6/13/11 |
Q311 | -$0.05 | N/A | N/A | $128.4K | $536.5K | N/A / N/A | N/A | -64.1% | Details | |
| 3/17/11 |
Q211 | -$0.07 | N/A | N/A | N/A | $3.22B | N/A / N/A | N/A | -78.6% | Details | |
| 12/15/10 |
Q111 | -$0.06 | N/A | N/A | N/A | N/A | N/A / N/A | N/A | -84.3% | Details |
